Jump to content

Adjuvance Technologies: Tyler Martin

Play
Episode 7
19 min / Published

Adjuvance Technologies is a vaccine research company that made waves in the Lincoln biotech startup community earlier this year, when it announced that it had raised a 20M series A round of funding - reportedly the largest series a round of funding ever in Nebraska history. And their CEO Tyler Martin, has an unlikely story coming from humble small town Nebraska.

___

Connect with the Nebraska Made | YouTube | Facebook | Instagram | LinkedIn

___

This show is produced by Grindstone.

Interested in starting a podcast? Visit grindstoneagency.com/podcasting to learn more.  

Episode ratings
Please log in or sign-up to rate this episode.
Episode comments

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
What do you think about this episode? Leave a comment!

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×

Important Information

By using this website, you accept the use of cookies in accordance with our Privacy Policy.